ARRY ASTX PIP ISCO AMBS - Investor Relations Responses Posted

I have posted another fresh set of investor relations (IR) questions and responses from biotechs provided by Mike O'Neill and covering financials and upcoming catalysts for each biotech stock. 

This round of responses features Amarantus Bioscience AMBS, Array Biopharma ARRY, Astex Pharma ASTX, International Stem Cell Corporation ISCO, and Pharmathene PIP.

Check out the complete index of all IR Questions and Answers if you missed the previous editions (covering >40 biotech and pharmaceutical companies)